Index RUT
P/E -
EPS (ttm) -0.41
Insider Own 14.51%
Shs Outstand 57.76M
Perf Week 14.65%
Market Cap 2.49B
Forward P/E 219.03
EPS next Y 0.20
Insider Trans -1.88%
Shs Float 49.70M
Perf Month 0.16%
Income -23.62M
PEG -
EPS next Q -0.20
Inst Own 86.05%
Short Float 7.97%
Perf Quarter -25.08%
Sales 520.66M
P/S 4.78
EPS this Y -1400.00%
Inst Trans 0.07%
Short Ratio 2.91
Perf Half Y -11.37%
Book/sh 7.71
P/B 5.55
EPS next Y 143.43%
ROA -4.04%
Short Interest 3.96M
Perf Year -33.56%
Cash/sh 1.75
P/C 24.45
EPS next 5Y -
ROE -5.41%
52W Range 36.73 - 71.85
Perf YTD -34.06%
Dividend Est. -
P/FCF 120.47
EPS past 5Y 32.83%
ROI -4.95%
52W High -40.42%
Beta 0.95
Dividend TTM -
Quick Ratio 2.19
Sales past 5Y 197.48%
Gross Margin 86.33%
52W Low 16.55%
ATR (14) 1.97
Dividend Ex-Date -
Current Ratio 2.71
EPS Y/Y TTM 23.19%
Oper. Margin -1.75%
RSI (14) 56.76
Volatility 4.68% 3.99%
Employees 1300
Debt/Eq 0.07
Sales Y/Y TTM 26.10%
Profit Margin -4.54%
Recom 1.45
Target Price 65.82
Option/Short Yes / Yes
LT Debt/Eq 0.07
EPS Q/Q -931.36%
Payout -
Rel Volume 0.64
Prev Close 41.84
Sales Surprise 3.89%
EPS Surprise -40.82%
Sales Q/Q 23.27%
Earnings Apr 30 AMC
Avg Volume 1.36M
Price 42.81
SMA20 7.63%
SMA50 -0.43%
SMA200 -24.51%
Trades
Volume 877,011
Change 2.32%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-29-24 Downgrade
Piper Sandler
Overweight → Neutral
$85 → $55
Jan-23-24 Initiated
Needham
Buy
$72
Jul-19-23 Initiated
Robert W. Baird
Outperform
$79
Oct-12-22 Initiated
Jefferies
Buy
$88
Sep-29-22 Initiated
Berenberg
Buy
$85
Sep-13-22 Initiated
Truist
Hold
$87
Jun-21-22 Initiated
Piper Sandler
Overweight
$100
Mar-23-22 Resumed
BofA Securities
Buy
$105
Dec-15-20 Upgrade
Wells Fargo
Equal Weight → Overweight
$79
Nov-18-20 Initiated
BTIG Research
Buy
$92
Oct-29-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$66 → $76
Sep-28-20 Initiated
SVB Leerink
Outperform
$80
Jun-19-20 Initiated
Canaccord Genuity
Buy
Jun-16-20 Initiated
Wells Fargo
Equal Weight
$49
Jun-16-20 Initiated
Morgan Stanley
Equal-Weight
$52
Jun-16-20 Initiated
BofA/Merrill
Neutral
$56
Show Previous Ratings
May-07-24 12:20PM
May-06-24 07:00AM
May-04-24 02:30AM
May-03-24 05:49PM
12:02PM
04:07PM
Loading…
May-02-24 04:07PM
May-01-24 12:19PM
10:59AM
07:42AM
(Thomson Reuters StreetEvents)
03:30AM
Apr-30-24 09:55PM
05:45PM
05:41PM
04:05PM
Apr-25-24 03:31PM
10:26AM
Loading…
Apr-22-24 10:26AM
Apr-19-24 10:09AM
Apr-18-24 01:25PM
Apr-17-24 04:05PM
Apr-15-24 10:52AM
Apr-11-24 04:05PM
03:33PM
Apr-09-24 11:04AM
Apr-02-24 04:05PM
Mar-29-24 11:30AM
Mar-25-24 06:15PM
Mar-20-24 07:01PM
Mar-14-24 10:45AM
Mar-12-24 09:00PM
04:05PM
11:30PM
Loading…
Mar-08-24 11:30PM
Mar-07-24 10:44AM
Feb-29-24 03:37PM
11:32AM
11:16AM
06:43AM
(Thomson Reuters StreetEvents)
Feb-28-24 04:37PM
04:05PM
Feb-14-24 04:05PM
Jan-23-24 07:16AM
Jan-15-24 03:13AM
Jan-12-24 12:16PM
Jan-09-24 06:30AM
Jan-08-24 09:00AM
Dec-20-23 04:01PM
Dec-15-23 07:24AM
Dec-01-23 11:31AM
Nov-30-23 11:19AM
Nov-27-23 04:20PM
Nov-18-23 07:03AM
Nov-15-23 04:05PM
07:59AM
Nov-06-23 09:35AM
Nov-03-23 12:27PM
10:59AM
10:31AM
08:59AM
07:01AM
Nov-02-23 07:16PM
04:01PM
11:03AM
11:02AM
(Thomson Reuters StreetEvents)
10:24AM
Nov-01-23 06:54PM
05:01PM
04:02PM
04:01PM
11:07AM
09:53AM
Oct-31-23 07:37AM
07:33AM
Oct-30-23 09:48AM
Oct-27-23 10:12AM
08:08AM
08:01AM
Oct-26-23 10:36AM
07:14AM
Oct-18-23 10:23PM
06:12AM
Oct-11-23 04:01PM
12:08PM
Oct-06-23 08:43AM
Sep-14-23 07:03PM
Aug-24-23 04:01PM
Aug-10-23 09:55AM
Aug-08-23 01:26PM
Aug-06-23 08:56AM
Aug-05-23 05:21AM
Aug-04-23 08:59AM
Aug-03-23 02:26PM
Aug-02-23 05:25PM
04:01PM
Jul-26-23 04:01PM
Jul-20-23 07:09AM
Jul-13-23 04:01PM
Jul-04-23 07:19AM
Jun-21-23 08:00PM
Jun-12-23 07:13AM
Jun-08-23 11:13AM
Jun-07-23 08:00AM
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hoffman William Director May 01 '24 Sale 42.00 38,549 1,619,047 965,359 May 03 05:40 PM Hoffman William Director Apr 16 '24 Sale 40.00 1,451 58,040 999,782 Apr 18 06:38 PM Hill, Mitch C. Chief Financial Officer Apr 12 '24 Option Exercise 0.46 6,000 2,742 187,294 Apr 16 04:32 PM Hill, Mitch C. Chief Financial Officer Apr 12 '24 Sale 40.96 6,000 245,760 181,294 Apr 16 04:32 PM Hoffman William Director Mar 18 '24 Sale 41.13 40,000 1,645,079 1,003,296 Mar 20 04:34 PM Hill, Mitch C. Chief Financial Officer Mar 12 '24 Option Exercise 0.46 6,000 2,742 189,361 Mar 14 04:31 PM Hill, Mitch C. Chief Financial Officer Mar 12 '24 Sale 41.91 6,000 251,461 183,361 Mar 14 04:31 PM Hoffman William Director Dec 15 '23 Sale 65.08 25,000 1,627,073 1,045,493 Dec 19 05:18 PM Hill, Mitch C. Chief Financial Officer Dec 12 '23 Option Exercise 0.46 6,500 2,970 176,730 Dec 14 04:35 PM Hill, Mitch C. Chief Financial Officer Dec 12 '23 Sale 62.75 6,500 407,855 170,230 Dec 14 04:35 PM Hoffman William Director Dec 04 '23 Option Exercise 0.43 103,492 44,336 1,070,493 Dec 06 05:07 PM Hykes Andrew President and CEO Nov 16 '23 Sale 59.82 37,448 2,240,277 434,817 Nov 17 07:17 PM Tu Thomas Chief Medical Officer Nov 16 '23 Sale 59.82 25,451 1,522,573 320,932 Nov 17 07:19 PM Hoffman William Director Nov 15 '23 Sale 61.24 25,000 1,531,124 967,001 Nov 17 06:27 PM Hill, Mitch C. Chief Financial Officer Nov 13 '23 Option Exercise 0.46 6,500 2,970 176,730 Nov 15 04:32 PM Hill, Mitch C. Chief Financial Officer Nov 13 '23 Sale 56.06 6,500 364,366 170,230 Nov 15 04:32 PM MILDER DONALD B Director Nov 08 '23 Buy 53.48 2,100 112,303 3,031,714 Nov 08 05:48 PM MILDER DONALD B Director Nov 07 '23 Buy 53.44 54,000 2,885,760 3,029,614 Nov 08 05:48 PM Hoffman William Director Oct 16 '23 Sale 57.28 25,000 1,432,098 992,001 Oct 18 05:39 PM Hill, Mitch C. Chief Financial Officer Oct 12 '23 Option Exercise 0.46 6,500 2,970 176,730 Oct 16 04:32 PM Hill, Mitch C. Chief Financial Officer Oct 12 '23 Sale 55.74 6,500 362,340 170,230 Oct 16 04:32 PM Hoffman William Director Sep 15 '23 Sale 66.74 25,000 1,668,503 1,023,055 Sep 19 04:38 PM Hill, Mitch C. Chief Financial Officer Sep 12 '23 Option Exercise 0.46 6,500 2,970 178,302 Sep 14 04:41 PM Hill, Mitch C. Chief Financial Officer Sep 12 '23 Sale 67.85 6,500 441,040 171,802 Sep 14 04:41 PM Hykes Andrew President and CEO Aug 16 '23 Sale 66.11 36,676 2,424,829 475,132 Aug 18 05:05 PM Tu Thomas Chief Medical Officer Aug 16 '23 Sale 66.11 24,926 1,647,980 347,997 Aug 18 05:01 PM Hoffman William Director Aug 15 '23 Sale 69.02 25,000 1,725,537 1,048,055 Aug 17 04:46 PM Hill, Mitch C. Chief Financial Officer Aug 14 '23 Option Exercise 0.46 6,500 2,970 178,302 Aug 16 04:46 PM Hill, Mitch C. Chief Financial Officer Aug 14 '23 Sale 70.47 6,500 458,053 171,802 Aug 16 04:46 PM Hoffman William Director Jul 17 '23 Sale 57.08 25,000 1,426,914 1,073,055 Jul 19 04:32 PM Hill, Mitch C. Chief Financial Officer Jul 12 '23 Option Exercise 0.46 6,500 2,970 177,982 Jul 14 04:35 PM Hill, Mitch C. Chief Financial Officer Jul 12 '23 Sale 56.24 6,500 365,540 171,482 Jul 14 04:35 PM Hoffman William Director Jun 15 '23 Sale 57.74 25,000 1,443,576 1,098,055 Jun 16 04:42 PM Hill, Mitch C. Chief Financial Officer Jun 12 '23 Option Exercise 0.46 6,500 2,970 179,554 Jun 13 05:48 PM Hill, Mitch C. Chief Financial Officer Jun 12 '23 Sale 59.24 6,500 385,088 173,054 Jun 13 05:48 PM ROOT JONATHAN D Director May 27 '23 Option Exercise 0.00 2,982 0 537,023 May 30 04:37 PM Nielsen Kirk G. Director May 27 '23 Option Exercise 0.00 2,982 0 61,479 May 30 04:35 PM MILDER DONALD B Director May 27 '23 Option Exercise 0.00 2,982 0 255,000 May 30 04:38 PM Hoffman William Director May 17 '23 Sale 69.19 41,891 2,898,438 1,120,643 May 18 08:18 PM Hykes Andrew President and CEO May 17 '23 Sale 69.19 18,760 1,298,004 513,608 May 18 08:16 PM Tu Thomas Chief Medical Officer May 17 '23 Sale 69.19 12,751 882,242 373,727 May 18 08:15 PM Hoffman William Director May 16 '23 Sale 70.87 40,006 2,835,225 1,162,534 May 18 08:18 PM Hykes Andrew President and CEO May 16 '23 Sale 70.87 17,916 1,269,707 532,368 May 18 08:16 PM Tu Thomas Chief Medical Officer May 16 '23 Sale 70.87 12,176 862,913 386,478 May 18 08:15 PM Hoffman William Director May 15 '23 Sale 70.51 25,000 1,762,860 1,202,540 May 18 08:18 PM Hill, Mitch C. Chief Financial Officer May 12 '23 Option Exercise 0.46 6,500 2,970 185,804 May 16 05:41 PM Hill, Mitch C. Chief Financial Officer May 12 '23 Sale 70.26 12,750 895,805 173,054 May 16 05:41 PM
Index S&P 500
P/E 36.89
EPS (ttm) 2.33
Insider Own 1.58%
Shs Outstand 601.10M
Perf Week 1.38%
Market Cap 51.73B
Forward P/E 27.56
EPS next Y 3.11
Insider Trans -4.34%
Shs Float 593.08M
Perf Month -7.04%
Income 1.41B
PEG 3.94
EPS next Q 0.69
Inst Own 82.48%
Short Float 1.24%
Perf Quarter -2.73%
Sales 6.14B
P/S 8.42
EPS this Y 10.40%
Inst Trans -0.08%
Short Ratio 2.08
Perf Half Y 27.99%
Book/sh 11.82
P/B 7.26
EPS next Y 12.42%
ROA 15.38%
Short Interest 7.38M
Perf Year -3.27%
Cash/sh 2.82
P/C 30.41
EPS next 5Y 9.36%
ROE 21.59%
52W Range 60.57 - 96.12
Perf YTD 12.58%
Dividend Est. -
P/FCF 190.59
EPS past 5Y 15.35%
ROI 18.14%
52W High -10.69%
Beta 1.11
Dividend TTM -
Quick Ratio 2.67
Sales past 5Y 10.28%
Gross Margin 76.11%
52W Low 41.72%
ATR (14) 1.95
Dividend Ex-Date -
Current Ratio 3.75
EPS Y/Y TTM -3.43%
Oper. Margin 27.71%
RSI (14) 41.49
Volatility 1.89% 2.21%
Employees 19800
Debt/Eq 0.10
Sales Y/Y TTM 11.68%
Profit Margin 23.01%
Recom 2.09
Target Price 95.94
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q 4.50%
Payout 0.00%
Rel Volume 0.52
Prev Close 85.09
Sales Surprise 1.80%
EPS Surprise 2.66%
Sales Q/Q 9.50%
Earnings Apr 25 AMC
Avg Volume 3.55M
Price 85.84
SMA20 -2.08%
SMA50 -4.48%
SMA200 9.45%
Trades
Volume 1,835,673
Change 0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Upgrade
BofA Securities
Neutral → Buy
Feb-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$94
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$80 → $77
Dec-11-23 Downgrade
Citigroup
Buy → Neutral
Nov-28-23 Downgrade
Wolfe Research
Peer Perform → Underperform
$57
Sep-26-23 Upgrade
Oppenheimer
Perform → Outperform
$90
Jul-19-23 Initiated
Robert W. Baird
Outperform
$107
May-30-23 Resumed
Morgan Stanley
Overweight
$102
Mar-29-23 Initiated
UBS
Neutral
$84
Mar-08-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$97 → $78
Feb-06-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-31-23 Downgrade
Bernstein
Outperform → Underperform
$95 → $66
Jan-30-23 Downgrade
Piper Sandler
Overweight → Neutral
$95 → $80
Dec-06-22 Downgrade
Stifel
Buy → Hold
$95 → $75
Oct-28-22 Downgrade
Oppenheimer
Outperform → Perform
Oct-26-22 Initiated
Mizuho
Buy
$100
Oct-18-22 Initiated
Barclays
Overweight
$96
Oct-12-22 Initiated
Jefferies
Buy
$110
Jul-29-22 Downgrade
Canaccord Genuity
Buy → Hold
$115 → $106
Apr-13-22 Initiated
Truist
Buy
$145
Show Previous Ratings
May-07-24 07:52AM
May-01-24 05:27PM
09:40AM
09:35AM
Apr-30-24 05:03PM
10:20AM
Loading…
10:20AM
Apr-29-24 02:22PM
12:18PM
07:23AM
Apr-26-24 04:09PM
(Investor's Business Daily)
11:21AM
11:09AM
10:54AM
10:42AM
10:38AM
(Thomson Reuters StreetEvents)
10:29AM
Loading…
10:29AM
09:53AM
08:28AM
03:40AM
Apr-25-24 06:00PM
05:52PM
05:30PM
05:04PM
(Investor's Business Daily)
04:34PM
04:26PM
(Associated Press Finance)
04:15PM
Apr-23-24 06:14AM
Apr-22-24 09:16AM
Apr-19-24 01:08AM
Apr-18-24 10:01AM
07:10AM
Loading…
07:10AM
Apr-17-24 11:01AM
Apr-12-24 04:37AM
Apr-07-24 04:30PM
Mar-26-24 08:02AM
Mar-25-24 09:40AM
Mar-19-24 02:24PM
(Investor's Business Daily)
01:38PM
Mar-15-24 04:02PM
10:50AM
Mar-13-24 11:57AM
Mar-11-24 02:00PM
Mar-07-24 04:57PM
11:31AM
Mar-06-24 09:43AM
Feb-26-24 11:54AM
Feb-23-24 07:05AM
Feb-18-24 01:26PM
Feb-15-24 09:36AM
Feb-13-24 12:09AM
Feb-09-24 02:21AM
Feb-07-24 04:11PM
(Investor's Business Daily)
11:19AM
10:31AM
09:06AM
(Thomson Reuters StreetEvents)
05:54AM
Feb-06-24 07:55PM
06:00PM
05:25PM
04:54PM
04:44PM
(Investor's Business Daily)
04:40PM
(Associated Press Finance)
04:15PM
07:18AM
Feb-02-24 07:00AM
06:27AM
Feb-01-24 09:15AM
07:44AM
Jan-30-24 07:05AM
06:15AM
Jan-23-24 07:07AM
Jan-19-24 11:26AM
Jan-16-24 01:20AM
Jan-03-24 07:40AM
Jan-02-24 09:00AM
Dec-20-23 05:24AM
Dec-14-23 07:49PM
Dec-11-23 12:27PM
Dec-08-23 05:11AM
Dec-07-23 05:00PM
08:30AM
Nov-26-23 05:56AM
Nov-25-23 06:58AM
Nov-24-23 11:31AM
Nov-23-23 06:06AM
Oct-30-23 11:40AM
Oct-27-23 07:30AM
Oct-26-23 06:15PM
03:06PM
02:00PM
11:33AM
11:17AM
11:12AM
10:08AM
07:23AM
07:20AM
(Thomson Reuters StreetEvents)
Oct-25-23 06:00PM
06:00PM
05:40PM
04:32PM
(Associated Press Finance)
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zovighian Bernard J CEO May 06 '24 Buy 85.74 580 49,753 3,268 May 07 05:53 PM Chopra Daveen CVP, TMTT May 04 '24 Option Exercise 0.00 4,713 0 27,172 May 06 07:17 PM BOBO DONALD E JR CVP,Strategy/Corp Development May 04 '24 Option Exercise 0.00 5,855 0 45,144 May 06 07:16 PM Ullem Scott B. CVP, Chief Financial Officer May 04 '24 Option Exercise 0.00 7,465 0 25,905 May 06 07:18 PM Szyman Catherine M. CVP, Critical Care May 04 '24 Option Exercise 0.00 5,796 0 49,018 May 06 07:18 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 04 '24 Option Exercise 0.00 4,157 0 177,969 May 06 07:18 PM Wood Larry L Global President TAVR & Surg May 04 '24 Option Exercise 0.00 6,675 0 220,022 May 06 07:17 PM Zovighian Bernard J CEO May 04 '24 Option Exercise 0.00 6,265 0 50,554 May 07 05:53 PM MUSSALLEM MICHAEL A Director May 02 '24 Option Exercise 36.75 29,350 1,078,612 33,836 May 02 06:05 PM MUSSALLEM MICHAEL A Director May 02 '24 Sale 84.77 29,350 2,487,966 4,486 May 02 06:05 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Option Exercise 36.75 14,400 529,200 188,249 May 01 05:17 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC May 01 '24 Sale 84.21 14,400 1,212,687 173,849 May 01 05:17 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Option Exercise 36.75 7,250 266,438 26,324 Apr 30 04:56 PM Ullem Scott B. CVP, Chief Financial Officer Apr 30 '24 Sale 85.80 7,250 622,062 19,074 Apr 30 04:56 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Option Exercise 36.75 857 31,495 18,345 Apr 09 05:33 PM Lippis Daniel J. CVP, JAPAC Apr 09 '24 Sale 92.34 857 79,135 17,488 Apr 09 05:33 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Option Exercise 36.75 14,400 529,200 188,249 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Option Exercise 36.75 12,500 459,375 52,268 Apr 08 05:10 PM Lemercier Jean-Luc M CVP, EMEACLA Apr 08 '24 Sale 92.32 14,400 1,329,472 173,849 Apr 08 05:10 PM BOBO DONALD E JR CVP,Strategy/Corp Development Apr 08 '24 Sale 92.33 12,500 1,154,142 39,768 Apr 08 05:10 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Apr 04 06:26 PM MUSSALLEM MICHAEL A Director Apr 04 '24 Sale 92.42 29,350 2,712,418 4,486 Apr 04 06:26 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Option Exercise 36.75 7,255 266,621 26,329 Apr 01 06:55 PM Ullem Scott B. CVP, Chief Financial Officer Apr 01 '24 Sale 94.89 7,255 688,423 19,074 Apr 01 06:55 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Option Exercise 36.75 14,500 532,875 54,003 Mar 13 05:44 PM BOBO DONALD E JR CVP,Strategy/Corp Development Mar 13 '24 Sale 91.01 14,500 1,319,696 39,503 Mar 13 05:44 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Option Exercise 36.75 14,400 529,200 187,984 Mar 11 06:00 PM Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Mar 11 '24 Sale 91.68 14,400 1,320,149 173,584 Mar 11 06:00 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Option Exercise 36.75 1,715 63,026 18,928 Mar 07 06:22 PM Lippis Daniel J. CVP, JAPAC Mar 07 '24 Sale 90.98 1,715 156,031 17,213 Mar 07 06:22 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Mar 04 07:16 PM MUSSALLEM MICHAEL A Director Mar 04 '24 Sale 86.67 29,350 2,543,737 4,486 Mar 04 07:16 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Option Exercise 36.75 7,255 266,621 26,329 Feb 29 05:12 PM Ullem Scott B. CVP, Chief Financial Officer Feb 29 '24 Sale 85.59 7,255 620,923 19,074 Feb 29 05:12 PM GALLAHUE KIERAN Director Feb 23 '24 Option Exercise 36.86 7,056 260,107 10,757 Feb 26 05:52 PM GALLAHUE KIERAN Director Feb 23 '24 Sale 87.61 3,058 267,911 67,219 Feb 26 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Option Exercise 59.26 7,000 414,797 30,950 Feb 21 05:52 PM Chopra Daveen CVP, TMTT Feb 21 '24 Sale 86.74 8,200 711,272 22,750 Feb 21 05:52 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Option Exercise 36.75 27,000 992,250 61,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 15 '24 Sale 85.62 27,000 2,311,654 34,814 Feb 15 05:25 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Option Exercise 36.75 20,000 735,000 54,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Option Exercise 36.75 11,000 404,250 50,503 Feb 13 04:51 PM Szyman Catherine M. CVP, Critical Care Feb 13 '24 Sale 86.46 20,000 1,729,200 34,814 Feb 15 05:25 PM BOBO DONALD E JR CVP,Strategy/Corp Development Feb 13 '24 Sale 85.83 11,000 944,155 39,503 Feb 13 04:51 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Option Exercise 36.75 12,210 448,718 25,297 Feb 12 05:44 PM SELLERS ROBERT W.A. SVP, Corporate Controller Feb 12 '24 Sale 87.00 12,210 1,062,270 13,087 Feb 12 05:44 PM STONE HEISZ LESLIE Director Feb 08 '24 Option Exercise 36.86 7,056 260,107 34,036 Feb 08 06:08 PM STONE HEISZ LESLIE Director Feb 08 '24 Sale 86.45 7,056 609,991 26,980 Feb 08 06:08 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Feb 05 06:37 PM MUSSALLEM MICHAEL A Director Feb 05 '24 Sale 87.49 29,350 2,567,754 4,486 Feb 05 06:37 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Option Exercise 36.75 7,255 266,621 26,503 Feb 01 05:52 PM Ullem Scott B. CVP, Chief Financial Officer Feb 01 '24 Sale 78.29 7,255 567,994 19,248 Feb 01 05:52 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Option Exercise 36.75 10,000 367,500 49,503 Jan 12 05:36 PM BOBO DONALD E JR CVP,Strategy/Corp Development Jan 12 '24 Sale 75.67 10,000 756,700 39,503 Jan 12 05:36 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Option Exercise 36.75 29,350 1,078,612 33,836 Jan 05 07:19 PM MUSSALLEM MICHAEL A Director Jan 05 '24 Sale 72.98 29,350 2,142,089 4,486 Jan 05 07:19 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Option Exercise 36.75 14,510 533,242 33,758 Dec 29 04:25 PM Ullem Scott B. CVP, Chief Financial Officer Dec 29 '23 Sale 76.55 14,510 1,110,794 19,248 Dec 29 04:25 PM Chopra Daveen CVP, TMTT Dec 15 '23 Option Exercise 59.26 7,000 414,797 30,950 Dec 15 05:22 PM Chopra Daveen CVP, TMTT Dec 15 '23 Sale 78.25 7,000 547,724 23,950 Dec 15 05:22 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Option Exercise 45.28 8,658 392,006 222,452 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Option Exercise 36.75 8,000 294,000 47,503 Dec 13 07:04 PM MUSSALLEM MICHAEL A Director Dec 13 '23 Sale 74.62 29,350 2,190,043 4,486 Dec 13 07:04 PM Wood Larry L Global President TAVR & Surg Dec 13 '23 Sale 71.86 8,658 622,164 213,794 Dec 13 07:04 PM BOBO DONALD E JR CVP,Strategy/Corp Development Dec 13 '23 Sale 71.86 8,000 574,880 39,503 Dec 13 07:04 PM Chopra Daveen CVP, TMTT Dec 06 '23 Option Exercise 59.26 3,500 207,398 27,450 Dec 06 05:01 PM Chopra Daveen CVP, TMTT Dec 06 '23 Sale 70.00 3,500 245,006 23,950 Dec 06 05:01 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Option Exercise 36.75 6,000 220,500 45,503 Nov 13 05:21 PM Wood Larry L Global President TAVR & Surg Nov 13 '23 Sale 65.30 8,660 565,460 213,794 Nov 13 05:21 PM BOBO DONALD E JR CVP,Strategy/Corp Development Nov 13 '23 Sale 65.30 6,000 391,780 39,503 Nov 13 05:21 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Nov 06 06:33 PM MUSSALLEM MICHAEL A Director Nov 03 '23 Sale 67.18 29,350 1,971,733 4,486 Nov 06 06:33 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Oct 31 05:22 PM Ullem Scott B. CVP, Chief Financial Officer Oct 31 '23 Sale 62.66 7,255 454,569 19,248 Oct 31 05:22 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Option Exercise 45.28 8,660 392,096 222,454 Oct 13 05:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Oct 13 '23 Option Exercise 36.75 5,000 183,750 44,503 Oct 13 05:01 PM Wood Larry L Global President TAVR & Surg Oct 13 '23 Sale 70.00 8,660 606,198 213,794 Oct 13 05:02 PM BOBO DONALD E JR CVP,Strategy/Corp Development Oct 13 '23 Sale 69.98 5,000 349,909 39,503 Oct 13 05:01 PM Szyman Catherine M. CVP, Critical Care Oct 10 '23 Option Exercise 36.75 5,000 183,750 39,814 Oct 10 06:23 PM Szyman Catherine M. CVP, Critical Care Oct 10 '23 Sale 72.68 5,000 363,400 34,814 Oct 10 06:23 PM Chopra Daveen CVP, TMTT Oct 03 '23 Option Exercise 59.26 8,500 503,682 32,450 Oct 03 04:58 PM Chopra Daveen CVP, TMTT Oct 03 '23 Sale 70.00 8,500 595,000 23,950 Oct 03 04:58 PM MUSSALLEM MICHAEL A Director Oct 02 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Oct 02 06:51 PM MUSSALLEM MICHAEL A Director Oct 02 '23 Sale 68.84 29,350 2,020,454 4,486 Oct 02 06:51 PM Ullem Scott B. CVP, Chief Financial Officer Sep 29 '23 Option Exercise 36.75 7,255 266,621 26,503 Sep 29 04:49 PM Ullem Scott B. CVP, Chief Financial Officer Sep 29 '23 Sale 69.54 7,255 504,527 19,248 Sep 29 04:49 PM Wood Larry L Global President TAVR & Surg Sep 14 '23 Option Exercise 45.28 8,660 392,096 222,454 Sep 14 08:00 PM BOBO DONALD E JR CVP,Strategy/Corp Development Sep 14 '23 Option Exercise 36.75 4,500 165,375 44,003 Sep 14 08:00 PM Wood Larry L Global President TAVR & Surg Sep 14 '23 Sale 73.63 8,660 637,615 213,794 Sep 14 08:00 PM BOBO DONALD E JR CVP,Strategy/Corp Development Sep 14 '23 Sale 73.71 4,500 331,695 39,503 Sep 14 08:00 PM Szyman Catherine M. CVP, Critical Care Sep 08 '23 Option Exercise 36.75 5,000 183,750 39,814 Sep 08 05:29 PM Szyman Catherine M. CVP, Critical Care Sep 08 '23 Sale 76.00 5,000 380,000 34,814 Sep 08 05:29 PM Chopra Daveen CVP, TMTT Sep 06 '23 Option Exercise 59.26 8,500 503,682 32,450 Sep 06 05:09 PM Chopra Daveen CVP, TMTT Sep 06 '23 Sale 76.07 8,500 646,609 23,950 Sep 06 05:09 PM MUSSALLEM MICHAEL A Director Sep 05 '23 Option Exercise 36.75 29,350 1,078,612 33,836 Sep 05 07:08 PM MUSSALLEM MICHAEL A Director Sep 05 '23 Sale 75.86 29,350 2,226,491 4,486 Sep 05 07:08 PM Ullem Scott B. CVP, Chief Financial Officer Aug 31 '23 Option Exercise 36.75 7,255 266,621 26,503 Aug 31 05:34 PM Ullem Scott B. CVP, Chief Financial Officer Aug 31 '23 Sale 77.79 7,255 564,366 19,248 Aug 31 05:34 PM
Index RUT
P/E -
EPS (ttm) -3.49
Insider Own 8.20%
Shs Outstand 50.32M
Perf Week 49.80%
Market Cap 191.43M
Forward P/E -
EPS next Y -1.80
Insider Trans -2.27%
Shs Float 46.36M
Perf Month 49.80%
Income -172.80M
PEG -
EPS next Q -0.55
Inst Own 106.54%
Short Float 18.51%
Perf Quarter 17.34%
Sales 130.38M
P/S 1.47
EPS this Y 22.82%
Inst Trans -4.76%
Short Ratio 7.07
Perf Half Y -10.82%
Book/sh 2.44
P/B 1.55
EPS next Y 13.86%
ROA -48.41%
Short Interest 8.58M
Perf Year -81.82%
Cash/sh 4.03
P/C 0.94
EPS next 5Y -
ROE -93.69%
52W Range 1.92 - 24.13
Perf YTD -29.94%
Dividend Est. -
P/FCF -
EPS past 5Y -15.08%
ROI -67.11%
52W High -84.29%
Beta 1.92
Dividend TTM -
Quick Ratio 4.37
Sales past 5Y 202.67%
Gross Margin 22.24%
52W Low 97.40%
ATR (14) 0.37
Dividend Ex-Date -
Current Ratio 5.26
EPS Y/Y TTM -2.89%
Oper. Margin -130.22%
RSI (14) 77.59
Volatility 18.67% 11.08%
Employees 480
Debt/Eq 1.11
Sales Y/Y TTM 13.00%
Profit Margin -132.54%
Recom 2.25
Target Price 5.79
Option/Short Yes / Yes
LT Debt/Eq 1.10
EPS Q/Q 10.34%
Payout -
Rel Volume 1.85
Prev Close 3.79
Sales Surprise 0.00%
EPS Surprise 7.81%
Sales Q/Q -4.69%
Earnings May 08 AMC
Avg Volume 1.21M
Price 3.79
SMA20 51.39%
SMA50 50.92%
SMA200 -43.69%
Trades
Volume 2,241,225
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-08-24 Initiated
BTIG Research
Buy
$6
Apr-05-24 Upgrade
CL King
Neutral → Buy
$6
Jan-12-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$14 → $6
Oct-13-23 Downgrade
BofA Securities
Buy → Underperform
$32 → $3
Aug-17-23 Initiated
CL King
Neutral
Nov-11-22 Initiated
RBC Capital Mkts
Outperform
$23
Jul-14-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$48 → $20
Mar-02-22 Resumed
BofA Securities
Buy
$50
Feb-17-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$50
Aug-18-21 Initiated
Cowen
Outperform
$70
Apr-19-21 Initiated
Wells Fargo
Overweight
$63
Dec-16-20 Initiated
Oppenheimer
Perform
Oct-12-20 Initiated
SVB Leerink
Mkt Perform
$60
Oct-12-20 Initiated
Stifel
Buy
$54
Oct-12-20 Initiated
Morgan Stanley
Equal-Weight
$48
Oct-12-20 Initiated
Goldman
Buy
$54
Oct-12-20 Initiated
BofA Securities
Buy
$54
Oct-12-20 Initiated
Barclays
Overweight
Show Previous Ratings
May-06-24 08:48AM
08:00AM
May-03-24 09:43AM
May-01-24 04:30PM
Apr-19-24 08:30AM
01:36PM
Loading…
Apr-18-24 01:36PM
Apr-17-24 08:30AM
Apr-15-24 08:30AM
Mar-13-24 04:02PM
Mar-05-24 03:34PM
(The Wall Street Journal)
Feb-26-24 09:00AM
Feb-22-24 10:51AM
07:10AM
(Thomson Reuters StreetEvents)
Feb-21-24 04:49PM
04:05PM
04:25PM
Loading…
Feb-20-24 04:25PM
Feb-05-24 10:00AM
08:30AM
Jan-08-24 08:30AM
Jan-03-24 08:30AM
Nov-29-23 04:05PM
Nov-25-23 11:43AM
Nov-23-23 06:30AM
Nov-16-23 02:46PM
Nov-09-23 04:05PM
Nov-07-23 04:31PM
04:05PM
Nov-02-23 10:00AM
09:35AM
Nov-01-23 09:00AM
02:00PM
Loading…
Oct-31-23 02:00PM
10:01AM
Oct-30-23 04:05PM
Oct-27-23 11:42AM
Oct-19-23 12:31PM
Oct-17-23 05:36PM
09:35AM
Oct-16-23 08:14AM
Oct-13-23 07:21PM
09:50AM
Oct-12-23 04:05PM
Aug-29-23 04:05PM
Aug-14-23 09:24PM
Aug-02-23 05:55PM
04:05PM
Jul-13-23 08:30AM
Jul-10-23 01:09PM
10:48AM
Jun-15-23 06:56AM
Jun-06-23 04:05PM
May-30-23 07:30AM
May-05-23 06:14AM
May-04-23 09:13AM
(Thomson Reuters StreetEvents)
May-03-23 06:35PM
04:05PM
Apr-30-23 05:50AM
Apr-25-23 08:30AM
Apr-23-23 07:03AM
Apr-12-23 09:05AM
08:30AM
Apr-03-23 07:01AM
Mar-25-23 08:26AM
Feb-22-23 04:05PM
Feb-17-23 04:16PM
Feb-15-23 05:54AM
Feb-14-23 12:10PM
Feb-13-23 05:45PM
04:05PM
Feb-07-23 10:00AM
Feb-06-23 10:00AM
Jan-25-23 08:30AM
Jan-09-23 08:30AM
Jan-03-23 06:10PM
Dec-23-22 05:20AM
Dec-22-22 11:21AM
Dec-20-22 04:05PM
Nov-28-22 08:00AM
Nov-26-22 05:00AM
Nov-16-22 09:09AM
Nov-11-22 01:15PM
Nov-09-22 07:24PM
04:05PM
Nov-08-22 06:25PM
04:05PM
Nov-04-22 08:30AM
Oct-27-22 09:00AM
Oct-26-22 04:05PM
Oct-24-22 06:36AM
Sep-21-22 03:24AM
Aug-30-22 04:05PM
Aug-15-22 09:00AM
Aug-09-22 09:44AM
Aug-04-22 06:27AM
Aug-02-22 08:45AM
Aug-01-22 11:15AM
11:14AM
10:02AM
Jul-28-22 09:44AM
Jul-21-22 09:30AM
Jul-13-22 09:55AM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Nash Marc SVP Operations and R&D Mar 15 '24 Sale 2.13 2,391 5,093 242,510 Mar 15 06:40 PM Ahmed Nabeel Chief Financial Officer Mar 01 '24 Sale 3.15 1,584 4,990 322,877 Mar 04 04:34 PM Trigg Leslie Chair and CEO Feb 15 '24 Sale 3.57 5,320 18,992 833,091 Feb 16 05:29 PM Ahmed Nabeel Chief Financial Officer Feb 15 '24 Sale 3.57 4,403 15,719 312,594 Feb 16 05:24 PM Brottem John L. General Counsel Feb 15 '24 Sale 3.57 3,341 11,927 245,046 Feb 16 05:26 PM Williamson Steven S. Chief Commercial Officer Feb 15 '24 Sale 3.57 2,500 8,925 320,347 Feb 16 05:31 PM Racine Jean-Olivier Chief Technology Officer Feb 15 '24 Sale 3.57 1,866 6,662 271,830 Feb 16 05:28 PM Nash Marc SVP Operations and R&D Feb 15 '24 Sale 3.57 617 2,203 243,100 Feb 16 05:27 PM Nash Marc SVP Operations and R&D Jan 16 '24 Sale 429.00 678 290,862 243,717 Jan 17 08:01 PM Trigg Leslie Chair and CEO Jan 16 '24 Sale 4.29 8,126 34,861 838,411 Jan 17 08:03 PM Ahmed Nabeel Chief Financial Officer Jan 16 '24 Sale 4.29 1,726 7,405 316,997 Jan 17 07:59 PM Brottem John L. General Counsel Jan 16 '24 Sale 4.29 1,480 6,349 248,387 Jan 17 08:00 PM Williamson Steven S. Chief Commercial Officer Jan 16 '24 Sale 4.29 996 4,273 322,847 Jan 17 08:04 PM Porter Stacey L. Chief People Officer Jan 16 '24 Sale 4.29 768 3,295 61,448 Jan 17 08:02 PM Racine Jean-Olivier Chief Technology Officer Jan 16 '24 Sale 4.29 723 3,102 273,696 Jan 17 08:03 PM Trigg Leslie Chair and CEO Jan 08 '24 Sale 5.49 14,188 77,892 389,099 Jan 08 08:34 PM Ahmed Nabeel Chief Financial Officer Jan 08 '24 Sale 5.49 10,709 58,792 76,819 Jan 08 08:29 PM Brottem John L. General Counsel Jan 08 '24 Sale 5.49 7,344 40,319 48,807 Jan 08 08:30 PM Williamson Steven S. Chief Commercial Officer Jan 08 '24 Sale 5.49 7,055 38,732 105,939 Jan 08 08:35 PM Porter Stacey L. Chief People Officer Jan 08 '24 Sale 5.49 4,766 26,165 58,630 Jan 08 08:31 PM Racine Jean-Olivier Chief Technology Officer Jan 08 '24 Sale 5.49 3,905 21,438 73,781 Jan 08 08:33 PM Williamson Steven S. Chief Commercial Officer Nov 16 '23 Sale 4.76 3,584 17,060 112,994 Nov 17 04:22 PM Trigg Leslie Chair and CEO Nov 16 '23 Sale 4.76 3,175 15,113 403,287 Nov 17 04:19 PM Ahmed Nabeel Chief Financial Officer Nov 16 '23 Sale 4.76 1,643 7,821 87,528 Nov 17 04:08 PM Brottem John L. General Counsel Nov 16 '23 Sale 4.76 1,431 6,812 56,151 Nov 17 04:15 PM Racine Jean-Olivier Chief Technology Officer Nov 16 '23 Sale 4.76 790 3,760 77,686 Nov 17 04:18 PM Porter Stacey L. Chief People Officer Nov 16 '23 Sale 4.76 671 3,194 63,396 Nov 17 04:17 PM Nash Marc SVP Operations and R&D Nov 16 '23 Sale 4.76 562 2,675 44,757 Nov 17 04:15 PM Ahmed Nabeel Chief Financial Officer Sep 01 '23 Sale 13.61 545 7,417 89,171 Sep 05 04:04 PM Trigg Leslie Chair and CEO Aug 16 '23 Sale 15.10 3,028 45,723 406,461 Aug 17 04:41 PM Ahmed Nabeel Chief Financial Officer Aug 16 '23 Sale 15.10 1,565 23,632 89,171 Aug 17 04:26 PM Brottem John L. General Counsel Aug 16 '23 Sale 15.10 1,364 20,596 57,581 Aug 17 04:28 PM Racine Jean-Olivier Chief Technology Officer Aug 16 '23 Sale 15.10 752 11,355 78,475 Aug 17 04:39 PM Porter Stacey L. Chief People Officer Aug 16 '23 Sale 15.10 638 9,634 64,066 Aug 17 04:37 PM Williamson Steven S. Chief Commercial Officer Aug 16 '23 Sale 15.10 635 9,588 116,577 Aug 17 04:43 PM Nash Marc SVP Operations and R&D Aug 16 '23 Sale 15.10 535 8,078 44,998 Aug 17 04:34 PM Trigg Leslie Chair and CEO Aug 01 '23 Option Exercise 4.11 20,000 82,200 429,489 Aug 03 04:11 PM Trigg Leslie Chair and CEO Aug 01 '23 Sale 20.22 20,000 404,462 409,489 Aug 03 04:11 PM Ahmed Nabeel Chief Financial Officer Aug 01 '23 Sale 20.07 990 19,869 90,736 Aug 03 04:10 PM Brottem John L. General Counsel Jul 19 '23 Option Exercise 9.48 1,415 13,414 60,360 Jul 20 04:01 PM Brottem John L. General Counsel Jul 19 '23 Sale 20.00 1,415 28,300 58,945 Jul 20 04:01 PM Trigg Leslie Chair and CEO Jul 03 '23 Option Exercise 4.11 20,000 82,200 429,489 Jul 05 05:39 PM Trigg Leslie Chair and CEO Jul 03 '23 Sale 20.90 20,000 417,944 409,489 Jul 05 05:39 PM Ahmed Nabeel Chief Financial Officer Jul 03 '23 Sale 21.70 990 21,483 91,726 Jul 05 05:38 PM Brottem John L. General Counsel Jun 20 '23 Option Exercise 9.48 1,414 13,405 60,359 Jun 21 04:01 PM Brottem John L. General Counsel Jun 20 '23 Sale 21.97 1,414 31,066 58,945 Jun 21 04:01 PM Trigg Leslie Chair and CEO Jun 01 '23 Option Exercise 4.11 20,000 82,200 429,489 Jun 01 06:08 PM Trigg Leslie Chair and CEO Jun 01 '23 Sale 21.10 20,000 421,920 409,489 Jun 01 06:08 PM Ahmed Nabeel Chief Financial Officer Jun 01 '23 Sale 20.83 990 20,622 92,716 Jun 01 05:31 PM Brottem John L. General Counsel May 17 '23 Option Exercise 9.48 1,415 13,414 61,677 May 17 06:26 PM Brottem John L. General Counsel May 17 '23 Sale 20.08 2,732 54,859 58,945 May 17 06:26 PM Trigg Leslie Chair and CEO May 16 '23 Sale 19.91 2,962 58,973 409,489 May 16 08:30 PM Ahmed Nabeel Chief Financial Officer May 16 '23 Sale 19.91 1,532 30,502 93,706 May 16 08:32 PM Brottem John L. General Counsel May 16 '23 Sale 19.91 1,335 26,580 60,262 May 17 06:26 PM Racine Jean-Olivier Chief Technology Officer May 16 '23 Sale 19.91 735 14,634 79,227 May 16 08:35 PM Williamson Steven S. Chief Commercial Officer May 16 '23 Sale 19.91 681 13,559 117,212 May 16 08:28 PM Porter Stacey L. Chief People Officer May 16 '23 Sale 19.91 626 12,464 64,704 May 16 08:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite